Methodology portfolio
Seven ways to build the evidence.
Each methodology exists because a specific decision required it. They are chosen by the challenge in front of you, the function that will use the result and the time you have. They almost always combine.
Catalogue
-
01 · continuous

Targeting
The quarterly platform: epidemiology, U&A, Brand Tracker and dynamic forecasting in a living model recalibrated against real prescription every wave.
4 waves/year · dashboard included
-
02 · ad hoc

Patient Journey
The patient route from the first symptoms through to adherence: diagnostic barriers, referral timing and intervention windows.
8–12 weeks · qualitative
-
03 · quantitative

Usage & Attitudes
Real prescribing habit: choice drivers, switching barriers and perceived efficacy and safety against the competitive set.
6–10 weeks · n ≥ 150
-
04 · longitudinal

Brand Tracker
Positioning measured wave after wave on a fixed panel: Top of Mind, share of prescription, NPS and brand equity with a competitive read.
quarterly wave · fixed panel
-
05 · modelling

Epidemiological models
Eligible-patient sizing by indication using ENSANUT, IMSS, Ministry of Health data and systematic review. Funnel by biomarker, sector and institution.
4–8 weeks · secondary sources
-
06 · dossier

Pharmacoeconomics / HEOR
Cost-effectiveness, cost-utility (QALY / ICER) and budget impact to ISPOR standards, built to withstand payer review.
12–20 weeks · value dossier
-
07 · bespoke

Ad hoc research
Message recall, copy testing, KOL mapping, advisory boards and real-world evidence. If the question does not fit a format, we design an ad hoc study.
per design · proposal in 48 h
Comparison
What to choose for the decision in front of you
| Methodology | Question it answers | Function | Typical sample | Timing |
|---|---|---|---|---|
| Targeting | How is my market moving quarter to quarter? | Marketing · BU | n ≥ 200 per wave | continuous |
| Patient Journey | Where exactly am I losing the patient? | Marketing · Medical | 25 qual + n ≥ 120 | 8–12 wks |
| Usage & Attitudes | What does the physician think of my brand, and why prescribe it? | Marketing | n ≥ 150 | 6–10 wks |
| Brand Tracker | Is my investment moving positioning? | Marketing | n ≥ 200 per wave | quarterly |
| Epidemiological models | How many eligible patients actually exist? | Access · BU | secondary sources | 4–8 wks |
| Pharmacoeconomics / HEOR | Does my product justify its price to the payer? | Market Access | model + KOL validation | 12–20 wks |
| Ad hoc research | The one that fits none of the above | Any | per design | per design |
None of them quite fits?
Describe the business question and we propose the design: method, sample, timing and deliverable. No cost, no commitment.
hola@scopusconsulting.com.mx
442 194 7770 · Mon–Fri 9:00–19:00 CT